Form D · Biotechnology
AcuityBio Corp
Newtonville, MA · CIK 0001722325
Offering snapshot reported Feb 10, 2020 · SEC filing
- Reported sold
- $175K Offering amount: $1.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 27, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 10, 2020 | Initial | $175,000 | No comparison | 4 | SEC filing |
| Nov 13, 2017 | Initial | $2,450,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-360159
Source: Form D, filed Feb 10, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karen English | Director, Executive |
| Mark W. Grinstaff | Director |
| Alain J. Hanover | Director |
| Peter Lui | Director |
| Eyal Ron | Director |
| John J. Schwartz | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
321 Walnut Street, #300
Newtonville, MA, 02460
Newtonville, MA, 02460